India to United States: Metoclopramide Export Trade Route

The India to United States Metoclopramide corridor is one of India's established pharmaceutical export routes, with 50 shipments documented worth a combined $3.1M USD. The route is dominated by AVET LIFESCIENCES PRIVATE LIMITED, which alone accounts for roughly 55% of all export value, reflecting the consolidated nature of India's metoclopramide manufacturing sector.

Across 8 active suppliers, the average shipment value stands at $62.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 79% of all shipments, consistent with metoclopramide's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 30 days port-to-port. The route has recorded an annual growth rate of 32.5%, placing it at rank #6 among India's top metoclopramide export destinations globally.

On the import side, key buyers of Indian metoclopramide in United States include AVET PHARMACEUTICALS INC, NA, AVET PHARMACEUTICALS INC. and 7 others. AVET PHARMACEUTICALS INC is the single largest importer with 14 shipments valued at $1.3M USD.

India's metoclopramide exports to United States are driven primarily by a handful of large-scale manufacturers. AVET LIFESCIENCES PRIVATE LIMITED with 18 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 8 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — AVET LIFESCIENCES PRIVATE LIMITED, IPCA LABORATORIES LIMITED, PFIZER HEALTHCARE INDIA PRIVATE LIMITED — together account for 91% of total trade value on this route. The average shipment value of $62.4K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as (medicines) metoclopramide inj. usp 10mg/2ml avet sn details as per invoice and medicines - metoclopramide inj. usp 10mg/2ml avet sn batch no. es230234a. date:oct/2023 exp.date:sep/2026, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, AVET PHARMACEUTICALS INC is the largest importer with 14 shipments worth $1.3M USD — representing 42% of all metoclopramide imports from India on this route. A total of 10 buyers are active on this corridor.